Traduction de «from an infected » (Néerlandais → Français) :

In het kader van de toegang van gezelschapsdieren tot het ziekenhuis, is het uiterst belangrijk er aan te herinneren dat tot op heden geen nosocomiale epidemies te wijten aan de aanwezigheid van gezelschapsdieren in het ziekenhuis werden beschreven maar dat een werkelijk risico van sporadische punctuele gevallen wel bestaat en goed beschreven is (in een brochure van de CDC « Preventing infections from pets – A guide for people with HIV infection » - referentie in bijlage).
Dans le cadre de l’accès des animaux de compagnie dans le milieu hospitalier, il est essentiel de rappeler qu’aucune épidémie nosocomiale imputable à la présence d’animaux de compagnie dans l’hôpital n’a encore été rapportée à ce jour mais cependant le risque réel pour des cas ponctuels sporadiques existe et est bien décrit (dans une brochure du CDC « Preventing infections from pets – A guide for people with HIV infection » - références en annexe).

Intervention When a MRSA colonised or infected patient leaves the hospital to receive ambulatory care, it is recommended that the general practitioner be fully informed of the follow-up of MRSA colonisation or infection through the discharge medical report and any additional standard document Patients recently hospitalised for more than 24 hours or transferred from another hospital or presenting risk factors for MRSA colonisation must be isolated.
Quand le patient colonisé ou infecté par MRSA quitte l’hôpital pour recevoir des soins ambulatoires, il est conseillé d’informer de manière complète le médecin généraliste du suivi de la colonisation ou de l’infection à MRSA au moyen du rapport médical de renvoi ou de tout document standard supplémentaire.

Gunson RN, Shouval D, Roggendorf M, Zaaijer H, Nicholas H, Holzmann H, et al. Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients.
Gunson RN, Shouval D, Roggendorf M, Zaaijer H, Nicholas H, Holzmann H, et al. Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs) : guidelines for prevention of transmission of HBV and HCV from HCW to patients.

Risk of hepatitis B and human immunodeficiency virus transmission to a patient from an infected surgeon due to percutaneous injury during an invasive procedure: estimates based on a model.
Risk of hepatitis B and human immunodeficiency virus transmission to a patient from an infected surgeon due to percutaneous injury during an invasive procedure : estimates based on a model.

Referentie: Transmissible spongiform encephalopathy agents: safe working and the prevention of infection, Annexe A.1, Guidance from the Advisory Committee on Dangerous Pathogens and the Spongiform Encephalopathy Advisory Committee, Department of Health UK, 2003.
Référence: Transmissible spongiform encephalopathy agents: safe working and the prevention of infection, Annexe A.1 , Guidance from the Advisory Committee on Dangerous Pathogens and the Spongiform Encephalopathy Advisory Committee, Department of Health UK, 2003.

Hirai Y. Survival of bacteria under dry conditions; from a viewpoint of nosocomial infection.
- Hirai Y. Survival of bacteria under dry conditions; from a viewpoint of nosocomial infection.

us women from a populatio n with a high rate of congenital CMV infection
multiparo us women from a populatio n with a high rate of congenital CMV infection

Clinical trials are underway in other age groups, including as young as from two months, to protect against the serogroups A, C, W-135 and Y found with this often-fatal bacterial infection.
Des essais cliniques sont en cours dans d’autres tranches d’âges, dès l’âge de deux mois, pour les protéger contre les sérogroupes A, C, W-135 et Y que l’on trouve dans cette maladie bactérienne souvent mortelle.

The reason behind this ambition is certainly not obvious: the competent medicines authorities in other Member States have the same ambition and vaccinology is, in epidemiological terms, a very broad domain, ranging from the prevention of neonatal pathology to hospital infections to sexually transmitted diseases.
The reason behind this ambition is certainly not obvious: the competent medicines authorities in other Member States have the same ambition and vaccinology is, in epidemiological terms, a very broad domain, ranging from the prevention of neonatal pathology to hospital infections to sexually transmitted diseases.

Recent estimates of the cost attributable to MRSA infection in hospitalised patients ranged from 10 000 to 36 000 Euros.
On a récemment estimé que le coût imputable à l'infection à MRSA chez les patients hospitalisés est compris entre 10 000 et 36 000 Euros.